ACTIVE

OBIPHAR

Financial year 2025 · Closed on 31/12/2025

Net result-1,2 k €-118,3 %over 1 year

Gross margin6,3 k €-35,0 %over 1 year

Equity118,8 k €-1,0 %over 1 year

Identity

Source · BCE/KBO

OBIPHAR is a Public limited company incorporated in 2005. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Frameries.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0878.100.418
Incorporation: 22/12/2005
Legal form: Public limited company
Registered office: Rue Montavaux 155
7080 Frameries · WallonieSee on map
Contributed capital: 100 000,00 €
Latest accounts: 31/12/2025

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Signals

Solid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 20 filings

Trend over 20 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	6,3 k €	-35.0%	9,7 k €	+33.3%	7,3 k €	-67.7%	22,6 k €	-0.2%	22,7 k €
EBITDA	5,9 k €	-36.6%	9,4 k €	+35.1%	6,9 k €	-68.9%	22,3 k €	-0.2%	22,3 k €
Operating result	-737 €	-108%	9,4 k €	+35.1%	6,9 k €	-68.9%	22,3 k €	-0.2%	22,3 k €
Net result	-1,2 k €	-118%	6,7 k €	+36.9%	4,9 k €	-70.7%	16,6 k €	-0.1%	16,6 k €
Balance sheet
Equity	118,8 k €	-1.0%	120,1 k €	+5.9%	113,4 k €	-23.7%	148,6 k €	+12.6%	132 k €
Total assets	218,8 k €	+82.3%	120,1 k €	-21.7%	153,4 k €	+2.4%	149,7 k €	+12.4%	133,3 k €
Cash	118,7 k €	+2.9%	115,3 k €	-22.3%	148,4 k €	-0.9%	149,7 k €	+12.3%	133,3 k €
Debts	100 k €		–		40 k €	+3242%	1,2 k €	-7.1%	1,3 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 3 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
FINPHARMARepresented by PHILIPPE BOULANGER	Director27/11/2023 → 26/11/2029
GESTIPHARMA0425.530.684Represented by PIERRE PASCAL HECQ	Managing director30/06/2017 → 26/11/2029

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
ANNE RIGOLET	Director30/06/2017 → 2022 accounts
UNIVERSAL PHARMA0447.382.113	Director30/06/2017 → 2022 accounts

Other companies at this address

Rue Montavaux 155 7080 Frameries

Company	CBE no.
ASSCOT● Active	0447.778.625
ATRIUM MANAGEMENT● Active	0478.169.913
BEPHAR● Active	0450.260.538
EVRAS● Active	0417.723.174
FARMIMMO● Active	0429.198.175
FELIX PHARMA● Active	0477.939.091
IMMOBILIERE DES QUATRE SEIGNEURIES● Active	0443.155.782
Immobilière Général Léman● Active	0403.358.761
IMMOBILIERE PRIMA● Active	0466.956.812
IMMOBILIERE SAINT GEORGES● Active	0435.700.442
Les Pharmacies Réunies● Active	0403.082.213
PHARMACIE ANDROMEDE● Active	0882.318.631
PHARMACIE CLAERHOUT● Active	0423.162.203
Pharmacie de la Chasse Royale● Active	0867.368.654
PHARMACIE DE LA PLACE DE GHLIN● Active	0842.900.009
PHARMACIE FAIDHERBE● Active	0479.179.208
Pharmacie Grenez - Seeuws● Active	0419.745.130
PHARMACIE RONDEAU● Active	0447.088.737
PHARMACIE SCHNEIDER - DEPOUHON● Active	0439.400.397
PHARMANET● Active	0426.485.640

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Micro model	Micro model	Micro model	Micro model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	30/06/2026	14/07/2025	06/08/2024	23/08/2023	16/08/2022	09/08/2021
General meeting	26/06/2026	27/06/2025	28/06/2024	28/06/2023	24/06/2022	25/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2025	26/06/2026	30/06/2026	French	PDF
Micro model	31/12/2024	27/06/2025	14/07/2025	French	PDF
Micro model	31/12/2023	28/06/2024	06/08/2024	French	PDF
Micro model	31/12/2022	28/06/2023	23/08/2023	French	PDF
Micro model	31/12/2021	24/06/2022	16/08/2022	French	PDF
Abridged model	31/12/2020	25/06/2021	09/08/2021	French	PDF
Abridged model	31/12/2019	26/06/2020	25/08/2020	French	PDF
Abridged model	31/12/2018	28/06/2019	07/08/2019	French	PDF
Abridged model	31/12/2017	29/06/2018	02/08/2018	French	PDF
Abridged model	31/12/2016	30/06/2017	04/07/2017	French	PDF
Abridged model	31/12/2015	24/06/2016	19/07/2016	French	PDF
Abridged model	31/12/2014	26/06/2015	13/08/2015	French	PDF
Abridged model	31/12/2013	27/06/2014	22/07/2014	French	PDF
Abridged model	31/12/2012	28/06/2013	29/07/2013	French	PDF
Abridged model	31/12/2011	29/06/2012	09/07/2012	French	PDF
Abridged model	31/12/2010	24/06/2011	08/07/2011	French	PDF
Abridged model	31/12/2009	25/06/2010	29/06/2010	French	PDF
Abridged model	31/12/2008	26/06/2009	23/07/2009	French	PDF
Abridged model	31/12/2007	27/06/2008	23/07/2008	French	PDF
Abridged model	31/12/2006	29/06/2007	20/07/2007	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 3 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
FINPHARMARepresented by PHILIPPE BOULANGER	Director27/11/2023 → 26/11/2029
GESTIPHARMA0425.530.684Represented by PIERRE PASCAL HECQ	Managing director30/06/2017 → 26/11/2029

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
ANNE RIGOLET	Director30/06/2017 → 2022 accounts
UNIVERSAL PHARMA0447.382.113	Director30/06/2017 → 2022 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates25/11/2024
DEMISSIONS, NOMINATIONS
PDF
Mandates27/12/2023
DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates04/10/2023
DEMISSIONS, NOMINATIONS
PDF
Mandates09/10/2017
DEMISSIONS, NOMINATIONS
PDF
Other21/10/2013
STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Capital / shares14/02/2012
CAPITAL, ACTIONS
PDF
Mandates11/01/2012
DEMISSIONS, NOMINATIONS
PDF
Other04/01/2006
CONSTITUTION
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings20 filings

Mandates

GESTIPHARMA

FINPHARMA

UNIVERSAL PHARMA

ANNE RIGOLET

PIERRE PASCAL HECQ

2005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029

OBIPHAR

Rue Montavaux 155, 7080 Frameries

Managing director

Director

Managing director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Rue Montavaux 155, 7080 FrameriesCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00237422

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
OBIPHARCurrent	accounts 2006 → 2025	Accounts 2025 · 2026-00237422

Events

2025
Annual accounts 2025-1,2 k €↓
2024
Annual accounts 20246,7 k €↑
2023
Annual accounts 20234,9 k €↓
2022
Annual accounts 202216,6 k €↓
2021
Annual accounts 202116,6 k €↓
2020
Annual accounts 202017,1 k €↑
2019
Annual accounts 20194,1 k €↓
2018
Annual accounts 20184,3 k €↓
2017
Annual accounts 201713,2 k €↓
2016
Annual accounts 201622,3 k €↑
2015
Annual accounts 2015-1,1 k €↓
2014
Annual accounts 2014-1,1 k €↑
2013
Annual accounts 2013-2,1 k €↑
2012
Annual accounts 2012-3,3 k €↓
2011
Annual accounts 2011-3 k €↑
2010
Annual accounts 2010-4,7 k €↑
2009
Annual accounts 2009-5,8 k €↑
2008
Annual accounts 2008-7 k €↑
2007
Annual accounts 2007-7,9 k €↑
2006
Annual accounts 2006-9,7 k €
22/12/2005
IncorporationPublic limited company

OBIPHAR

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events